相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of EML4-ALK Variant on Resistance Mechanisms and Clinical Outcomes in ALK-Positive Lung Cancer
Jessica J. Lin et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
The AP-1-BATF and-BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma
Nikolai Schleussner et al.
LEUKEMIA (2018)
GCC2-ALK as a targetable fusion in lung adenocarcinoma and its enduring clinical responses to ALK inhibitors
Junhong Jiang et al.
LUNG CANCER (2018)
ALK in Neuroblastoma: Biological and Therapeutic Implications
Ricky M. Trigg et al.
CANCERS (2018)
Treatment Options for Paediatric Anaplastic Large Cell Lymphoma (ALCL): Current Standard and beyond
Nina Prokoph et al.
CANCERS (2018)
Differential protein stability and clinical responses of EML4-ALK fusion variants to various ALK inhibitors in advanced ALK-rearranged non-small cell lung cancer
C. G. Woo et al.
ANNALS OF ONCOLOGY (2017)
Novel ALK fusion in anaplastic large cell lymphoma involving EEF1G, a subunit of the eukaryotic elongation factor-1 complex
G. Palacios et al.
LEUKEMIA (2017)
Anaplastic lymphoma kinase L1198F and G1201E mutations identified in anaplastic thyroid cancer patients are not ligand-independent
Jikui Guan et al.
ONCOTARGET (2017)
Diagnosis and Treatment of Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer
Kathryn C. Arbour et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2017)
Pyrimidine tract-binding protein 1 mediates pyruvate kinase M2-dependent phosphorylation of signal transducer and activator of transcription 3 and oncogenesis in anaplastic large cell lymphoma
Steven R. Hwang et al.
LABORATORY INVESTIGATION (2017)
Dynamic intramolecular regulation of the histone chaperone nucleoplasmin controls histone binding and release
Christopher Warren et al.
NATURE COMMUNICATIONS (2017)
The long non-coding RNA LINC01013 enhances invasion of human anaplastic large-cell lymphoma
I-Hsiao Chung et al.
SCIENTIFIC REPORTS (2017)
Performance of a RT-PCR Assay in Comparison to FISH and Immunohistochemistry for the Detection of ALK in Non-Small Cell Lung Cancer
David R. Hout et al.
CANCERS (2017)
The role of anaplastic lymphoma kinase in pediatric cancers
Junko Takita
CANCER SCIENCE (2017)
The Truncated Isoform of the Receptor Tyrosine Kinase ALK Generated by Alternative Transcription Initiation (ALKATI) Induces Chromatin Structural Changes in the Nucleus in a Kinase Activity-Dependent Manner
Yuki Takakura et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2017)
Effects of SMYD2-mediated EML4-ALK methylation on the signaling pathway and growth in non-small-cell lung cancer cells
Rui Wang et al.
CANCER SCIENCE (2017)
Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency
M. Ceccon et al.
ONCOGENE (2016)
Long noncoding RNA hotair mediated angiogenesis in nasopharyngeal carcinoma by direct and indirect signaling pathways
Wei-ming Fu et al.
ONCOTARGET (2016)
Upregulation of PD-L1 by EML4-ALK fusion protein mediates the immune escape in ALK positive NSCLC: Implication for optional anti-PD-1/PD-L1 immune therapy for ALK-TKIs sensitive and resistant NSCLC patients
Shaodong Hong et al.
ONCOIMMUNOLOGY (2016)
Nucleophosmin: from structure and function to disease development
Joseph K. Box et al.
BMC MOLECULAR BIOLOGY (2016)
ALK Protein Protein Analysis by IHC Staining after Recent Regulatory Changes: A Comparison of Two Widely Used Approaches, Revision of the Literature, and a New Testing Algorithm
Antonio Marchetti et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Coupling an EML4-ALK-centric interactome with RNA interference identifies sensitizers to ALK inhibitors
Guolin Zhang et al.
SCIENCE SIGNALING (2016)
Anaplastic large cell lymphoma arises in thymocytes and requires transient TCR expression for thymic egress
Tim I. M. Malcolm et al.
NATURE COMMUNICATIONS (2016)
Insights into the Pathogenesis of Anaplastic Large-Cell Lymphoma through Genome-wide DNA Methylation Profiling
Melanie R. Hassler et al.
CELL REPORTS (2016)
Coupling an EML4-ALK-centric interactome with RNA interference identifies sensitizers to ALK inhibitors
Guolin Zhang et al.
SCIENCE SIGNALING (2016)
Microtubule association of EML proteins and the EML4-ALK variant 3 oncoprotein require an N-terminal trimerization domain
Mark W. Richards et al.
BIOCHEMICAL JOURNAL (2015)
Novel ALK fusion partners in lung cancer
Aglaya G. Iyevleva et al.
CANCER LETTERS (2015)
Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches
Alexander Drilon et al.
CLINICAL CANCER RESEARCH (2015)
French multicentric validation of ALK rearrangement diagnostic in 547 lung adenocarcinomas
Sylvie Lantuejoul et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth
Coralie Hoareau-Aveilla et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation
Olaf Merkel et al.
JOURNAL OF PATHOLOGY (2015)
Alternative transcription initiation leads to expression of a novel ALK isoform in cancer
Thomas Wiesner et al.
NATURE (2015)
microRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers
Pierluigi Gasparini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
DNA methylation reprogramming in cancer: Does it act by re-configuring the binding landscape of Polycomb repressive complexes?
James P. Reddington et al.
BIOESSAYS (2014)
ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma
Scott C. Bresler et al.
CANCER CELL (2014)
PCAT-1, a Long Noncoding RNA, Regulates BRCA2 and Controls Homologous Recombination in Cancer
John R. Prensner et al.
CANCER RESEARCH (2014)
The role of miR-150 in normal and malignant hematopoiesis
Y. He et al.
ONCOGENE (2014)
Crystal structure of EML1 reveals the basis for Hsp90 dependence of oncogenic EML4-ALK by disruption of an atypical β-propeller domain
Mark W. Richards et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer
Lindsey M. Kelly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Transcriptional regulatory functions of nuclear long noncoding RNAs
Keith W. Vance et al.
TRENDS IN GENETICS (2014)
microRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma
Cuiling Liu et al.
BLOOD (2013)
Genome-Wide Epigenetic Regulation of miRNAs in Cancer
Constance Baer et al.
CANCER RESEARCH (2013)
Novel TRAF1-ALK Fusion Identified by Deep RNA Sequencing of Anaplastic Large Cell Lymphoma
Andrew L. Feldman et al.
GENES CHROMOSOMES & CANCER (2013)
Long Noncoding RNAs: Past, Present, and Future
Johnny T. Y. Kung et al.
GENETICS (2013)
DNA Methylation and Its Basic Function
Lisa D. Moore et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Epigenetic Silencing of the Proapoptotic Gene BIM in Anaplastic Large Cell Lymphoma through an MeCP2/SIN3a Deacetylating Complex
Rocco Piazza et al.
NEOPLASIA (2013)
Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology
Bengt Hallberg et al.
NATURE REVIEWS CANCER (2013)
A Prospective PCR-Based Screening for the EML4-ALK Oncogene in Non-Small Cell Lung Cancer
Manabu Soda et al.
CLINICAL CANCER RESEARCH (2012)
Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non-Small Cell Lung Cancer
Robert C. Doebele et al.
CLINICAL CANCER RESEARCH (2012)
Differential Protein Stability and ALK Inhibitor Sensitivity of EML4-ALK Fusion Variants
Johannes M. Heuckmann et al.
CLINICAL CANCER RESEARCH (2012)
Increased miR-708 Expression in NSCLC and Its Association with Poor Survival in Lung Adenocarcinoma from Never Smokers
Jin Sung Jang et al.
CLINICAL CANCER RESEARCH (2012)
Discovery of ALK-PTPN3 gene fusion from human non-small cell lung carcinoma cell line using next generation RNA sequencing
Yeonjoo Jung et al.
GENES CHROMOSOMES & CANCER (2012)
MicroRNAs are shaping the hematopoietic landscape
Ute Bissels et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
A Novel EML4-ALK Variant Exon 6 of EML4 Fused to Exon 19 of ALK
Roland Penzel et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Next-Generation Sequencing Identifies and Immunohistochemistry Confirms a Novel Crizotinib-Sensitive ALK Rearrangement in a Patient with Metastatic Non-Small-Cell Lung Cancer
Nir Peled et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer
P. Lopez-Serra et al.
ONCOGENE (2012)
KLC1-ALK: A Novel Fusion in Lung Cancer Identified Using a Formalin-Fixed Paraffin-Embedded Tissue Only
Yuki Togashi et al.
PLOS ONE (2012)
A Genomic Regulatory Element That Directs Assembly and Function of Immune-Specific AP-1-IRF Complexes
Elke Glasmacher et al.
SCIENCE (2012)
Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers
Ryohei Katayama et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
The Multifunctional Protein Nucleophosmin (NPM1) Is a Human Linker Histone H1 Chaperone
Shrikanth S. Gadad et al.
BIOCHEMISTRY (2011)
miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma
Hironori Matsuyama et al.
BLOOD (2011)
CpG islands and the regulation of transcription
Aimee M. Deaton et al.
GENES & DEVELOPMENT (2011)
MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells
Jing-Hua Li et al.
GYNECOLOGIC ONCOLOGY (2011)
Knockdown of NPM1 by RNA Interference Inhibits Cells Proliferation and Induces Apoptosis in Leukemic Cell Line
Feng-Xian Qin et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2011)
Determining the contribution of NPM1 heterozygosity to NPM-ALK-induced lymphomagenesis
Fiona K. E. McDuff et al.
LABORATORY INVESTIGATION (2011)
IL-2R common γ-chain is epigenetically silenced by nucleophosphin-anaplastic lymphoma kinase (NPM-ALK) and acts as a tumor suppressor by targeting NPM-ALK
Qian Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Exon scanning by reverse transcriptase-polymerase chain reaction for detection of known and novel EML4-ALK fusion variants in non-small cell lung cancer
Heather R. Sanders et al.
CANCER GENETICS (2011)
NPM1/B23: AMultifunctional Chaperone in Ribosome Biogenesis and Chromatin Remodeling
Mikael S. Lindstrom
BIOCHEMISTRY RESEARCH INTERNATIONAL (2011)
Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain
Christian C. Lee et al.
BIOCHEMICAL JOURNAL (2010)
The cytoplasmic NPM mutant induces myeloproliferation in a transgenic mouse model
Ke Cheng et al.
BLOOD (2010)
A Novel, Highly Sensitive Antibody Allows for the Routine Detection of ALK-Rearranged Lung Adenocarcinomas by Standard Immunohistochemistry
Mari Mino-Kenudson et al.
CLINICAL CANCER RESEARCH (2010)
Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma
Olaf Merkel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
miR-155 gene: A typical multifunctional microRNA
Isabella Faraoni et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
NPM-ALK Oncogenic Tyrosine Kinase Controls T-Cell Identity by Transcriptional Regulation and Epigenetic Silencing in Lymphoma Cells
Chiara Ambrogio et al.
CANCER RESEARCH (2009)
KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer
Kengo Takeuchi et al.
CLINICAL CANCER RESEARCH (2009)
Nucleophosmin Blocks Mitochondrial Localization of p53 and Apoptosis
Sanjit Kumar Dhar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Exon Array Profiling Detects EML4-ALK Fusion in Breast, Colorectal, and Non-Small Cell Lung Cancers
Eva Lin et al.
MOLECULAR CANCER RESEARCH (2009)
Linking DNA methylation and histone modification: patterns and paradigms
Howard Cedar et al.
NATURE REVIEWS GENETICS (2009)
Lack of TNFα expression protects anaplastic lymphoma kinase-positive T-cell lymphoma (ALK plus TCL) cells from apoptosis
Qian Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Epigenetic changes and suppression of the nuclear factor of activated T cell 1 (NFATC1) promoter in human lymphomas with defects in immunoreceptor, signaling
Askar Akimzhanov et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer
Young Lim Choi et al.
CANCER RESEARCH (2008)
Multiplex Reverse Transcription-PCR Screening for EML4-ALK Fusion Transcripts
Kengo Takeuchi et al.
CLINICAL CANCER RESEARCH (2008)
EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer
Jussi P. Koivunen et al.
CLINICAL CANCER RESEARCH (2008)
Lysine 263 residue of NPM/B23 is essential for regulating ATP binding and B23 stability
Joung Woo Choi et al.
FEBS LETTERS (2008)
Transcription regulation of the rRNA gene by a multifunctional nucleolar protein, B23/nucleophosmin, through its histone chaperone activity
Kensaku Murano et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation
Zhaoliang Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A mouse model for EML4-ALK-positive lung cancer
Manabu Soda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The structure and functions of NPM1/Nucleophsmin/B23, a multifunctional nucleolar acidic protein
Mitsuru Okuwaki
JOURNAL OF BIOCHEMISTRY (2008)
The anaplastic lymphoma kinase in the pathogenesis of cancer
Roberto Chiarle et al.
NATURE REVIEWS CANCER (2008)
Crystal structure of human nucleophosmin-core reveals plasticity of the pentamer-pentamer interface
Hyung Ho Lee et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2007)
STAT5A is epigenetically silenced by the tyrosine kinase NPM1-ALK and acts as a tumor suppressor by reciprocally inhibiting NPM1-ALK expression
Qian Zhang et al.
NATURE MEDICINE (2007)
NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma
Annamaria Galietta et al.
BLOOD (2007)
NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma
Vasiliki Leventaki et al.
BLOOD (2007)
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Manabu Soda et al.
NATURE (2007)
The NPM-ALK tyrosine kinase mimics TCR signalling pathways, inducing NFAT and AP-1 by RAS-dependent mechanisms
Suzanne D. Turner et al.
CELLULAR SIGNALLING (2007)
Echinoderm microtubule-associated protein like protein 4, a member of the echinoderm microtubule-associated protein family, stabilizes microtubules
S. H. Houtman et al.
NEUROSCIENCE (2007)
Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf
M. Marzec et al.
ONCOGENE (2007)
Human EML4, a novel member of the EMAP family, is essential for microtubule formation
Marc Pollmann et al.
EXPERIMENTAL CELL RESEARCH (2006)
Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma
Yajun Han et al.
BLOOD (2006)
NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses
Konstantin D. Taganov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes
Qian Zhang et al.
BLOOD (2006)
SHP1 tyrosine phosphatase negatively regulates NPM-ALK tyrosine kinase signaling
Jean-Francois Honorat et al.
BLOOD (2006)
Nucleophosmin is essential for ribosomal protein L5 nuclear export
Yue Yu et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Multi-gene epigenetic silencing of tumor suppressor genes in T-cell lymphoma cells; delayed expression of the p16 protein upon reversal of the silencing
T Nagasawa et al.
LEUKEMIA RESEARCH (2006)
Human RISC couples microRNA biogenesis and posttranscriptional gene silencing
RI Gregory et al.
CELL (2005)
Human histone chaperone nucleophosmin enhances acetylation-dependent chromatin transcription
V Swaminathan et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication
W Wang et al.
NATURE CELL BIOLOGY (2005)
Biological role of anaplastic lymphoma kinase in neuroblastoma
Y Osajima-Hakomori et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target
R Chiarle et al.
NATURE MEDICINE (2005)
Identification of NPM-ALK interacting proteins by tandem mass spectrometry
DK Crockett et al.
ONCOGENE (2004)
Differential effects of X-ALK fusion proteins on proliferation, transformation, and invasion properties of NIH3T3 cells
F Armstrong et al.
ONCOGENE (2004)
Preferential binding of the histone (H3-H4)2 tetramer by NAP1 is mediated by the amino-terminal histone tails
SJ McBryant et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Identification and characterization of a nuclear interacting partner of anaplastic lymphoma kinase (NIPA)
T Ouyang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy
F Chang et al.
LEUKEMIA (2003)
Neuroblastoma: Biological insights into a clinical enigma
GM Brodeur
NATURE REVIEWS CANCER (2003)
Histone chaperones and nucleosome assembly
CW Akey et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2003)
Targeting ras signalling pathways in cancer therapy
J Downward
NATURE REVIEWS CANCER (2003)
Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor
J Cools et al.
GENES CHROMOSOMES & CANCER (2002)
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death
A Zamo et al.
ONCOGENE (2002)
The oncoprotein 18/stathmin family of microtubule destabilizers
L Cassimeris
CURRENT OPINION IN CELL BIOLOGY (2002)
The human EMAP-like protein-70 (ELP70) is a microtubule destabilizer that localizes to the mitotic apparatus
B Eichenmüller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Function of nucleophosmin/B23, a nucleolar acidic protein, as a histone chaperone
M Okuwaki et al.
FEBS LETTERS (2001)
Translocations involving anaplastic lymphoma kinase (ALK)
J Duyster et al.
ONCOGENE (2001)
Anaplastic lymphoma kinase proteins and malignancy
K Pulford et al.
CURRENT OPINION IN HEMATOLOGY (2001)
Janus kinases: components of multiple signaling pathways
SG Rane et al.
ONCOGENE (2000)
Nucleophosmin/B23 is a target of CDK2/Cyclin E in centrosome duplication
M Okuda et al.
CELL (2000)
Mapping the functional domains of nucleolar protein B23
K Hingorani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors
B Lawrence et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
ATIC-ALK:: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35)
GWB Colleoni et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Conservation of the WD-repeat, microtubule-binding protein, EMAP, in sea urchins, humans, and the nematode C-elegans
KA Suprenant et al.
DEVELOPMENT GENES AND EVOLUTION (2000)
分享论文
